Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 31

Learn what SMAD4 loss means in pancreatic cancer, how IHC and sequencing detect it, what studies show about prognosis, and why SMAD4 is not yet a stand-alone treatment target.

SMAD4 Test for Pancreatic Cancer: Tumor Suppressor Marker, Loss, and Prognosis

Learn what an AKT1 mutation test detects, what AKT1 E17K means, how results guide advanced breast cancer treatment, and how tumor and blood testing differ.

AKT1 Mutation Test: Breast Cancer, Solid Tumors, AKT Pathway, and Mutation...

Learn what an ALK fusion test detects, how NGS, FISH, and IHC differ, what an ALK-positive lung cancer result means, and how it guides targeted therapy.

ALK Fusion Test: Gene Fusion, Lung Cancer Marker, Positive Result, and...

Learn how APC mutation testing relates to familial adenomatous polyposis, colon cancer risk, germline versus tumor variants, mosaicism, and family testing.

APC Mutation Test: Colon Cancer, Familial Adenomatous Polyposis, Variant Meaning, and...

Learn what an ASXL1 mutation test means in AML, MDS, CMML, MPNs, and clonal hematopoiesis, including prognosis, VAF, and risk interpretation.

ASXL1 Mutation Test: Myeloid Cancer, Prognosis, Mutation Status, and Risk Meaning

Learn what an ATM mutation test means for DNA repair, hereditary breast and prostate cancer risk, tumor testing, variant classification, screening, and family follow-up.

ATM Mutation Test: DNA Repair Gene, Breast Cancer Risk, Prostate Cancer...

Learn what a BCL2 rearrangement FISH test means in follicular lymphoma, how t(14;18) is interpreted, and how MYC plus BCL2 defines double-hit disease.

BCL2 Rearrangement Test: Follicular Lymphoma, Double-Hit Lymphoma, and FISH Result

BCL6 rearrangement testing uses FISH to clarify lymphoma genetics, prognosis context, and MYC/BCL2-related classification; learn what positive and negative results mean.

BCL6 Rearrangement Test: Lymphoma, Prognosis, Rearrangement Status, and FISH Result

BCR-ABL1 testing diagnoses Philadelphia chromosome-positive CML and tracks molecular response; learn PCR levels, International Scale milestones, resistance, and monitoring.

BCR-ABL1 Test: CML, Leukemia, Philadelphia Chromosome, and Molecular Monitoring

BRAF mutation testing identifies V600E and related drivers in melanoma, colon, thyroid, and lung cancer; understand methods, positive results, prognosis, and targeted therapy.

BRAF Mutation Test: V600E, Melanoma, Colon, Thyroid, Lung Cancer, and Mutation...

BRCA1 mutation testing identifies hereditary DNA-repair risk; learn pathogenic variant and VUS meaning, breast and ovarian cancer risks, family inheritance, and next steps.

BRCA1 Mutation Test: Hereditary Cancer Risk, DNA Repair, Variant Meaning, and...

Understand BRCA2 mutation testing, hereditary cancer risk, DNA repair, pathogenic variants, VUS results, germline vs tumor findings, and family testing.

BRCA2 Mutation Test: Hereditary Cancer Risk, DNA Repair, Variant Meaning, and...

Learn what a BTK mutation test means in leukemia and lymphoma, including C481 and non-C481 resistance mutations, negative results, testing methods, and treatment relevance.

BTK Mutation Test: Leukemia, Lymphoma, Drug Resistance Marker, and Mutation Meaning

Understand CALR mutation testing for essential thrombocythemia and myelofibrosis, including type 1 and type 2 variants, platelet findings, negative results, prognosis, and next steps.

CALR Mutation Test: Myeloproliferative Neoplasm, Platelets, Myelofibrosis, and Result Meaning

Learn how cancer gene mutation panels and molecular profiling work, what actionable and uncertain variants mean, how tissue and liquid biopsy differ, and when germline testing is needed.

Cancer Gene Mutation Panel: Tumor Mutations, Gene Variants, Diagnostic Meaning, and...

Understand CDK4 amplification testing in liposarcoma, including copy-number gain, MDM2 co-amplification, FISH and NGS methods, result meaning, diagnosis, and treatment relevance.

CDK4 Amplification Test: Liposarcoma, Copy Number Gain, Cancer Marker, and Tumor...

1...303132...137 Page 31 of 137